Stay updated on Daratumumab Combo in Resistant Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Resistant Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added 2015 ( U.S. NIH Grant/Contract ) to the list of Other Study ID Numbers and updated the page revision to v3.6.6 (replacing v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T19:48:14.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Deleted the disease label 'Multiple myeloma' and the related topics entry 'MedlinePlus Genetics', altering how the study’s condition and its linked resources are displayed on the page.
    Difference
    0.1%
    Check dated 2026-08-22T20:52:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The related topics section now lists 'Multiple myeloma' and 'MedlinePlus Genetics,' providing quick context for readers researching the disease. This addition enhances navigation and access to background information without altering the core study details.
    Difference
    0.1%
    Check dated 2026-08-15T23:20:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5. This change updates the displayed version information on the Study Details page to reflect the latest revision.
    Difference
    0.0%
    Check dated 2026-08-08T18:07:24.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added Revision: v3.6.4 and removed the prior revision reference (v3.6.3) along with keywords such as 'Multiple myeloma' and 'MedlinePlus Genetics' from the metadata.
    Difference
    0.2%
    Check dated 2026-07-25T10:52:10.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' and 'MedlinePlus Genetics' as related topics on the study page to provide disease context and quick access to a related patient information resource. This improves navigation and discoverability for readers seeking information about the condition.
    Difference
    0.1%
    Check dated 2026-07-18T05:42:40.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Resistant Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.